Metachronous occurrence of anal melanoma and papillary thyroid carcinoma in a 72-year-old female: Case in images

@#Anal melanoma is a rare melanocytic malignancy, which roughly comprises 2% of all anorectal malignancies.1 2 The anal area is the most common site for primary gastrointestinal melanomas.2 Patients with anal melanomas commonly complain of bleeding, anal pain and mass, tenesmus, and changes in bowel habits. In cases with metastases, symptoms such as weight loss, anemia, fatigue and bowel obstruction could be present.2 Risk factors of anal melanoma include old age, multiple sexual partners, anal sex, smoking, history of other malignancies (i.e., cervical, vulvar, or vaginal cancer), activation of the receptor tyrosine kinase c-Kit, and family history of malignancies.3 4 The diagnosis of anal melanoma is established through biopsy—usually done with colonoscopy—and immunological staining.5 HMB-45 is the immunological stain commonly used for the detection of both primary and metastatic melanomas.6 Endoscopic ultrasonography also helps to characterize lesions and assess the depth of infiltration.7

Postoperative outcomes of patients with severe obesity who underwent laparoscopic sleeve gastrectomy: Case series

@#Globally, especially in the Asian and African regions, there has been a rising burden of obesity due to high consumption of energy-dense foods and the increase of physical inactivity caused by urbanization and sedentary lifestyle changes.1 Bariatric surgery, or weight-loss surgery, remains to be the most effective treatment for morbid obesity, and it also has resulted in a substantial improvement of obesity-related comorbidities, especially type 2 diabetes mellitus.